16+
Major trials tracked
Targeted & bispecific oncology · Live ClinicalTrials.gov data
Zanubrutinib (Brukinsa) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 zanubrutinib (Brukinsa) trials on ClinicalTrials.gov by enrolment, 7 of them actively recruiting. The next phase 3 primary completion among them is expected Jan 2027. Refreshed daily. Add up to four competitors to compare pipelines side by side.
3
Phase 3 trials
7
Actively recruiting
Jan 2027
Next phase 3 primary completion
2,578
Participants across trials
BeiGene
Lead sponsor by trial count
zanubrutinib (16)13 active2017–2034
zanubrutinib
'17
'19
'21
'23
'25
'27
'29
'31
'33
zanubrutinib
ROSEWOODP2
MAGNOLIAP2
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) TreatmentP2
Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin LymphomaP3
BRUIN-MCL-321P3
Rituximab,Zanubrutinib in Combination With Lenalidomide, Followed by Zanubrutinib or Lenalidomide Maintenance in Patients With Primary or Secondary CNS LymphomaP2
R-ICE+XP2
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaP2
Pola-ZR2P in Previously Untreated DLBCLP2
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCLP2
ZeTAP2
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular LymphomaP2
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell MalignanciesP2
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLLP3
GUIDANCE-10P2
ZEN-CLLP2
Upcoming readouts
10 ahead · zanubrutinib
Select a trial to load its full ClinicalTrials.gov record.
Key zanubrutinib trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track zanubrutinib with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for zanubrutinib?
- ClinicalTrials.gov lists more than 16 phase 2–4 zanubrutinib trials. This page tracks the 16 largest by enrolment: 13 phase 2, 3 phase 3, and 0 phase 4 among them, with 7 actively recruiting. Updated daily.
- Are there clinical trials for Brukinsa?
- Brukinsa is the brand name for zanubrutinib, so zanubrutinib trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 zanubrutinib trials. This page tracks the 16 largest by enrolment: 13 phase 2, 3 phase 3, and 0 phase 4 among them, with 7 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare zanubrutinib against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.